Rezolute said it is discussing its sunRIZE trial with the FDA and may have next steps. The filing reports no FDA decision or trial result, so it does not change the company's prospects.
The FDA discussions could lead to next steps, but the filing does not say the FDA agreed to a plan or changed the trial. It also reports no trial result, so there is no clear change to Rezolute's prospects.
Follow Rezolute, Inc. (RZLT) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for RZLT